Ziółkowska S, Kijek N, Zendran I, Szuster E, Barg E. Familial hypercholesterolemia – treatment update in children, systematic review. Pediatric Endocrinology Diabetes and Metabolism. 2022;28(2):152-161. doi:10.5114/pedm.2022.116112.
APA
Ziółkowska, S., Kijek, N., Zendran, I., Szuster, E., & Barg, E. (2022). Familial hypercholesterolemia – treatment update in children, systematic review. Pediatric Endocrinology Diabetes and Metabolism, 28(2), 152-161. https://doi.org/10.5114/pedm.2022.116112
Chicago
Ziółkowska, Sabina, Noëlle Kijek, Iga Zendran, Ewa Szuster, and Ewa Barg. 2022. "Familial hypercholesterolemia – treatment update in children, systematic review". Pediatric Endocrinology Diabetes and Metabolism 28 (2): 152-161. doi:10.5114/pedm.2022.116112.
Harvard
Ziółkowska, S., Kijek, N., Zendran, I., Szuster, E., and Barg, E. (2022). Familial hypercholesterolemia – treatment update in children, systematic review. Pediatric Endocrinology Diabetes and Metabolism, 28(2), pp.152-161. https://doi.org/10.5114/pedm.2022.116112
MLA
Ziółkowska, Sabina et al. "Familial hypercholesterolemia – treatment update in children, systematic review." Pediatric Endocrinology Diabetes and Metabolism, vol. 28, no. 2, 2022, pp. 152-161. doi:10.5114/pedm.2022.116112.
Vancouver
Ziółkowska S, Kijek N, Zendran I, Szuster E, Barg E. Familial hypercholesterolemia – treatment update in children, systematic review. Pediatric Endocrinology Diabetes and Metabolism. 2022;28(2):152-161. doi:10.5114/pedm.2022.116112.
Familial hypercholesterolaemia is one of the most common genetic diseases, and its first symptoms occur in childhood. Proper diagnosis and treatment prevent young patients from severe consequences in their future. The treatment of this dyslipidaemia is still evolving, and new promising agents are being discovered. In this review we summarize the old and new treatment methods of familial hypercholesterolaemia, giving an update estimated on the latest publications.
